Paul-Lukas Hoffschmidt 0:04
So I'm going to present to you today Alpha Sophia. We are metric commercialization platform supporting med tech companies, but actually anyone selling to the healthcare market in commercializing their product. My name is Paul, I'm a co founder and angel investor invested in something like 20. Startups stop counting at some point. And we together with my co founders, Isabel and Robin founded Alpha Sophia back in 2022. And we are on a mission of making healthcare intelligence, accessible and affordable for Young Innovators for startups and SMBs. In the space, anyone here so that those kinds of insights can be used to bring those innovations of companies bring out to patients faster. So every med tech company goes through the same life cycle, starting from a development and r&d focus from an improved focus, where the main question is, how can I innovate the most and launch to market the fastest to a pure marketing and sales focus on where the question becomes? How can I can I get my innovations, my products out to the users to clinicians, and then ultimately, to those patients faster. And our mission is to support those companies on the second part of that journey, and help them get those innovations out there. So I mean, all of you have probably seen that chart, it's not new. And the big question always is, how do you cross the chasm in that journey, commercializing those products, and we see our mission in helping those companies make the initial jump. Now find those early adopters, you want to speak to find those initial adopters who then spread the word, bring your products, to those patients, get initial results, and then go up the curve, finding an earlier majority and, and bringing the product out. But I mean, that's easier said than it's done. As we all know, it takes a long, long time to actually succeed in those markets. On average, it takes something like 10 to 15 years for medical innovations to finally reach mass adoption in their respective markets. So we've asked ourselves, what can we do as enablers as accelerators to build a technology that helps those companies reach mass adoption a little bit faster, and then ultimately have an impact at a faster rate. So one of the levers we are seeing is using data and actually making that possible. So we are leaning in towards supplying data and targeting solutions for medtech companies to help them steep that adoption curve, they are getting a little bit farther further to the left, and to ultimately enable them to bring those innovations out there at a faster rate. How do we do that? So our our focus is one little wheel in the system is to help provide the actionable insights. And so everyone knows spreadsheet dumps and, and data sheet there a data sheet there now, but what we want to do is to actually present that data, which is, which helps us companies in a way that sales and marketing teams can actually use it for their commercial efforts and and in the end, get the biggest bang for the buck. They are spending on their sales and marketing efforts. That's not new. There are other solutions in the market doing that. But what we figured is that oftentimes, the dinosaurs in the industry are pricing out younger innovators in the market. And are we are we in a situation where many startups and I've talked to many at this conference today just can't afford spending top dollars for those solutions are leaving them with a weaker strategic positioning compared to compared to the big players they're up against. And what we try to do is build a solution, which is really powerful, but yet affordable that startups can use it at an early stage. And then can compete with power with larger companies who are already we have big big teams and big data science teams, crunching the data all day. So that's what we've been doing, we are making that accessible for everyone. And today, we're going to share a big announcement with you, as we've now launched our next evolution of our of our platform now, including all payer claims data for something like 80% of the whole healthcare market in our solution. And we're really confident that with this solution, we are now the most affordable but at the same time most most powerful solution the market, especially a good fit for Yeah, those innovators out there who have hopefully can use our solution to bring their products are faster. So thanks, again for for joining the session today. And yeah, if you're interested in that, get in touch, reach out to us book a demo and see a philosophy and action. Thank you
© 2024 Life Science Intelligence, Inc., All Rights Reserved.
